Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights May 15, 2023 07:00AM
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights Mar 28, 2023 07:30AM
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights Mar 28, 2023 07:30AM
Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights Nov 14, 2022 07:30AM
Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights Nov 14, 2022 07:30AM


Sep 29, 2022 07:00AM Zynerba Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
Sep 29, 2022 07:00AM Zynerba Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
Aug 10, 2022 07:00AM Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
Aug 10, 2022 07:00AM Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
May 16, 2022 07:00AM Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
May 16, 2022 07:00AM Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
Mar 22, 2022 07:00AM Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit
Mar 22, 2022 07:00AM Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit
May 12, 2021 06:45AM Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights
May 12, 2021 06:45AM Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights
Mar 10, 2021 06:45AM Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 10, 2021 06:45AM Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Aug 10, 2020 06:45AM Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
May 19, 2020 06:48AM Companies with NDRs 5/19
Sep 21, 2018 07:34AM Cantor Fitzgerald Starts Zynerba Pharmaceuticals (ZYNE) at Overweight
Jul 20, 2018 09:11AM Zynerba Pharma (ZYNE) Prices 4.06M Offering of Common Stock at $8/Sh
Jul 20, 2018 09:10AM Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jul 19, 2018 04:12PM Zynerba Pharma (ZYNE) Announces Proposed Common Share Offering
Jul 19, 2018 04:04PM Zynerba Pharmaceuticals (ZYNE) Plans Public Offering of Common Stock
Jul 19, 2018 04:01PM Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jul 19, 2018 04:01PM Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jul 12, 2018 09:15AM Pre-Open Movers 07/12: (ZGNX) (GLMD) (CA) Higher; (ZN) (ACRX) (AVGO) Lower (more...)
Oct 2, 2017 09:32AM Pre-Open Movers 10/02: (RIGL) (SNCR) (TRN) Higher; (JWN) (GNW) (ROKU) Lower (more...)
Oct 2, 2017 06:54AM UPDATE: Cantor Fitzgerald Upgrades Zynerba Pharmaceuticals (ZYNE) to Overweight
Aug 14, 2017 10:08AM Morning Movers 8/14: (CVM) (NEFF) (EGLT) (FCAU) (ZYNE)
Aug 7, 2017 11:36AM UPDATE: Cantor Fitzgerald Downgrades Zynerba Pharmaceuticals (ZYNE) to Neutral
Feb 9, 2017 07:35AM Zynerba Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Jan 19, 2017 09:17AM Zynerba Pharma (ZYNE) Prices 2.8M Shares at $18 Per Share
Jan 19, 2017 09:16AM Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Dec 21, 2016 04:09PM Cantor Fitzgerald Starts Zynerba Pharmaceuticals (ZYNE) at Overweight
Jul 6, 2016 07:00AM Zynerba Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference